KACTUS Blog

Targeting the Prostate Cancer Landscape: The Offensive and Defensive Strategies of PSMA, STEAP1, and KLK2

Targeting the Prostate Cancer Landscape: The Offensive and Defensive Strategies of PSMA, STEAP1, and KLK2

CA9: A Key Molecule Driving Tumor Invasion and Metastasis

CA9: A Key Molecule Driving Tumor Invasion and Metastasis

TfR1 Brain Delivery Track Key Domain: Apical Domain

TfR1 Brain Delivery Track Key Domain: Apical Domain

Targeting CTF: A New Choice for CDCP1 Tumor Therapy

Targeting CTF: A New Choice for CDCP1 Tumor Therapy

CEACAM5: From Classic Tumor Marker to Hot Target for Next-Generation ADCs/Bispecific Antibodies

CEACAM5: From Classic Tumor Marker to Hot Target for Next-Generation ADCs/Bispecific Antibodies

KLK5/7: Emerging Targets for Inflammatory Skin Diseases

KLK5/7: Emerging Targets for Inflammatory Skin Diseases

KACTUS Unveils Ultra-low Endotoxin Recombinant Protein Line — Powering Cleaner, Faster, Smarter Drug Discovery

KACTUS Unveils Ultra-low Endotoxin Recombinant Protein Line — Powering Cleaner, Faster, Smarter Drug Discovery

The New Frontier in SCLC Treatment: 4 Antigens Driving Antibody Innovation

The New Frontier in SCLC Treatment: 4 Antigens Driving Antibody Innovation

STEAP1, the Next Blockbuster Target for Prostate Cancer

STEAP1, the Next Blockbuster Target for Prostate Cancer

1 2 3 4

KACTUS Blog

↑